This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Alper Consultoria e Corretora de Seguros Valuation

Is APER3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of APER3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate APER3's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate APER3's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for APER3?

Key metric: As APER3 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for APER3. This is calculated by dividing APER3's market cap by their current revenue.
What is APER3's PS Ratio?
PS Ratio	2.8x
Sales	R$337.95m
Market Cap	R$953.27m

APER3 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3x
Enterprise Value/EBITDA	15x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does APER3's PS Ratio compare to its peers?

The above table shows the PS ratio for APER3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	0.6x
WIZC3 Wiz Co Participações e Corretagem de Seguros	0.7x	-1.0%	R$967.4m
VOT Votum	1x	n/a	zł369.6m
IRBR3 IRB-Brasil Resseguros	0.5x	-2.1%	R$3.3b
A211050 INCAR FINANCIAL SERVICE	0.4x	6.2%	₩317.0b
APER3 Alper Consultoria e Corretora de Seguros	2.8x	n/a	R$953.3m

Price-To-Sales vs Peers: APER3 is expensive based on its Price-To-Sales Ratio (2.8x) compared to the peer average (0.7x).

Price to Sales Ratio vs Industry

How does APER3's PS Ratio compare vs other companies in the South American Insurance Industry?

0 Companies	Price / Sales	Estimated Growth	Market Cap

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: APER3 is expensive based on its Price-To-Sales Ratio (2.8x) compared to the South American Insurance industry average (0.6x).

Price to Sales Ratio vs Fair Ratio

What is APER3's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

APER3 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2.8x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate APER3's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Globe Life

US$9.4b

Through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States.

G1LL34

US$31.91

10.3%

Aegon

€9.6b

Provides insurance, pensions, retirement, and asset management services in the United States, the Netherlands, the United Kingdom, and internationally.

A1EG34

€37.27

3.0%

38.2%